Mounjaro Maintenance Dose UK 2026: The Long-Term Guide

Published on: April 17, 2026

Medically reviewed by

Ashis Tandukar

Superintendent Pharmacist · Reg: GPhC No. 2084170

The scale hasn't moved in three weeks. Your jeans fit differently, your blood pressure sits in a healthier range, and your clinician has asked whether you want to talk about next steps. For most people on Mounjaro, this is the moment the conversation shifts — from losing weight to keeping it off.

That shift has a name: the maintenance phase. And the dose you settle on here — your Mounjaro maintenance dose — will do most of the work over the next year and beyond.

What is the Mounjaro maintenance dose?

The maintenance dose is the weekly dose of Mounjaro (tirzepatide) that keeps your weight stable once you've reached a weight you're happy with. It's different from the dose that got you there — which, for most people, was the dose they were titrating up through when the weight loss happened.

In UK practice, three doses get used for maintenance: 5mg, 10mg, and 15mg. All are available as KwikPens, delivered once a week.

There's no single "correct" maintenance dose. Someone who responded strongly at 7.5mg and lost the weight they wanted might settle there. Another person may only stabilise at 15mg. What matters is that the dose you're on keeps hunger, food noise, and appetite at manageable levels — without generating side effects that make daily life harder.

It's worth separating two ideas that often get confused:

• Titration dose: the gradually escalating doses (2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg) you climbed through while losing weight
• Maintenance dose: the steady weekly dose you continue on after you've reached your goal, chosen to preserve that result

For more on how titration works in the build-up phase, see our Mounjaro dosage guide.

When should you transition to maintenance?

There's no number on the scale that flips the switch. But there are a handful of clinical signals clinicians look for — and that you can watch for yourself:

• Your weight has stabilised for 3–4 weeks at a level you're content with, without deliberate calorie restriction beyond your usual eating pattern
• Appetite is steady — food noise remains quiet, you're not constantly thinking about the next meal, cravings aren't a daily battle
• Side effects are minimal on your current dose, or fully manageable
• Your health markers have improved: blood pressure, HbA1c, lipids, liver function (if they were off before)
• You feel genuinely well — not just thinner

If three or four of those apply, you're likely ready for a maintenance conversation. If you're still actively losing half a kilo or more per week and feel hungry, you're probably not there yet — you may still be in the weight-loss phase.

The timing varies enormously. In the SURMOUNT-1 trial, most participants hit their weight plateau between months 9 and 14. Real-world experience in UK pharmacy settings is similar — most people reach a personal plateau somewhere between 12 and 18 months.

Choosing between 5mg, 10mg and 15mg

The three common UK maintenance doses of Mounjaro aren't interchangeable. Each suits a different type of response.

The instinct for many patients is to stay on whatever dose produced the weight loss — the thinking being, if it worked to get me here, it'll work to keep me here. That's reasonable, but not always right.

A lot of people find they can step down one level during maintenance without regaining weight. The reason: you no longer need the appetite reduction to drop pounds, only to hold them. A 10mg dose that felt gently appetite-suppressing while you were losing weight may be more than enough to prevent regain.

The practical approach most UK clinicians take:

1. Stay at your final weight-loss dose for 8–12 weeks after you've plateaued
2. If your weight is stable and side effects are low, consider staying where you are
3. If side effects are bothersome, or you want to try a lower long-term cost, drop one dose level and monitor for 8–12 weeks
4. If weight starts creeping up (more than 2–3% over four weeks), return to the previous dose

This is a slower, more deliberate process than titrating up — because the consequences of getting it wrong are easier to spot quickly.

What the evidence actually says about maintenance

The strongest evidence comes from the SURMOUNT-4 trial, published in JAMA in December 2023. The design matters: everyone in the study spent 36 weeks losing weight on tirzepatide (averaging 20.9% body weight loss). Then participants were randomised either to continue tirzepatide or switch to placebo, for another 52 weeks.

The results were stark. People who continued tirzepatide kept losing — a further 5.5% on average, reaching a total loss of around 25% from baseline. Those who switched to placebo regained about 14% of their body weight within a year.

The regain group still ended up lighter than they started — but they gave back a significant portion of their progress while changing nothing about their diet or activity.

This is the clearest argument for a maintenance dose. It's not that Mounjaro is addictive or that your body "needs" it. It's that the underlying biology of weight regulation — the same biology that drove you towards obesity in the first place — reasserts itself when the medication stops. Without that ongoing support, most people regain.

For a wider view of what happens physiologically when treatment stops, see our guide on what happens when you stop taking Mounjaro.

Side effects during maintenance

For most people, side effects settle markedly by the time they reach maintenance. Your body has had 6–18 months to adapt to tirzepatide. Nausea that was troublesome in month two is usually a distant memory by month twelve.

Where side effects do persist into maintenance, they tend to be:

• Mild nausea after a higher-calorie or fattier meal — often improved by smaller portions and eating more slowly
• Reflux or heartburn, especially if lying down soon after eating
• Constipation, which is dose-related and often helps with fibre, fluid, and a regular walking habit
• Occasional low energy, particularly if protein intake has dropped as appetite has fallen

If any of these are still significant at 10mg or 15mg, stepping down to the next dose is a reasonable option to discuss with your prescriber. For day-to-day management, our full piece on Mounjaro side effects goes into more detail.

One thing to watch for: if side effects that had disappeared suddenly reappear during maintenance, that's unusual. It sometimes signals a change in your metabolism, a gastric issue unrelated to Mounjaro, or a supply-related change in the medication itself. Worth a conversation with your clinician.

What Mounjaro maintenance costs in the UK (2026)

Private Mounjaro prices shifted after the autumn 2025 pricing changes, so the figures below reflect what most UK online pharmacies are charging in early 2026. Expect variation of £10–£30 between providers.

Two things worth noting:

The step-down economics. Moving from 15mg to 10mg typically saves around £30–£40 per month, which adds up to £360–£480 per year. That's a meaningful reason to test whether a lower dose holds your weight — not just a clinical one.

NHS vs private. If you meet the NHS eligibility criteria (generally BMI ≥40, or BMI ≥35 with a weight-related condition, and referral through specialist weight management services), Mounjaro can be prescribed on the NHS. In practice, NHS capacity remains limited and waiting lists are long. Most UK patients on Mounjaro pay privately. See our full piece on Mounjaro cost in the UK for the detail.

How long can you stay on Mounjaro?

Indefinitely, is the technical answer. There's no licensed time limit on tirzepatide for obesity — you can remain on it for as long as you and your prescriber agree it's the right treatment.

The more useful question is: should you?

A common misunderstanding is that weight loss medication is a short-term fix, like a course of antibiotics. Obesity research doesn't support that framing. The chronic-disease model — which applies to conditions like hypertension and type 2 diabetes — fits obesity better. You manage it, often long-term, sometimes for life.

What that means in practice:

• Some people stay on Mounjaro for 2–3 years, then step down gradually and maintain on lifestyle alone
• Others remain on a low maintenance dose indefinitely because their appetite and weight rebound without it
• A smaller group comes off completely after their first year and maintains — typically those whose weight gain was recent, had a specific trigger (life event, medication), or was moderate

None of these paths are right or wrong. They reflect different bodies and different circumstances. Your clinician's job is to help you think through which is likely to work for you, based on how much weight you lost, how quickly it came on in the first place, and what happened to your appetite when you were on Mounjaro.

Coming off Mounjaro: what actually happens to your body

If you do choose to stop — either because you've reached your goal and want to try maintaining without medication, or for other reasons — it helps to understand what's happening biologically.

Three things change when tirzepatide leaves your system (a process that takes about 25–30 days from your last dose):

Appetite-regulating hormones return to baseline. GLP-1 and GIP receptors are no longer being activated by the medication. Your natural levels of these hormones, and the related hunger signals like ghrelin, return to where they were before treatment — which, in many people with obesity, means elevated hunger signals.

Metabolic adaptation persists. When you lose weight, your body burns fewer calories than someone of the same current weight who was never heavier. This is measurable and durable — it doesn't immediately reverse when you stop the medication. So you're managing a heightened appetite with a lower metabolic rate: the exact conditions for regain.

Food noise often comes back. Many people describe a gradual return of intrusive thoughts about food over the first two to three months after stopping. This isn't a personal failing — it's the return of appetite signalling that was being suppressed by the medication. If this happens and becomes distressing, our piece on food noise explains what's happening and what helps.

Staying alert to these shifts, rather than being surprised by them, is the single most useful thing you can do in the first 90 days after stopping. Weigh yourself more often, not less. Plan meals. Keep contact with your clinician open.

Monitoring during maintenance — not set-and-forget

Maintenance isn't a hands-off phase. Your check-ins with a clinician should continue, even if less frequently than during titration. A reasonable minimum is every 3–4 months.

What a good maintenance review covers:

• Current weight and trajectory (stable, drifting up, still gently falling)
• Side effects — new, persistent, or resolving
• Blood pressure
• HbA1c or fasting glucose, particularly if you have or had prediabetes
• Lipid panel roughly annually
• Liver function, roughly annually
• How appetite and food noise feel
• Whether the current dose still feels right

If anything here shifts noticeably — particularly weight creeping upwards or appetite returning — that's useful data. It doesn't necessarily mean you need to go back up a dose, but it's worth a conversation before you drift further.

The bottom line

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting any treatment.